Shampa Das

发表

Randomized, placebo‐controlled study to assess the impact on QT/QTc interval of supratherapeutic doses of ceftazidime–avibactam or ceftaroline fosamil–avibactam

T. Edeki, Jianguo Li, Shampa Das, 2014, Journal of clinical pharmacology.

Dose Selection and Validation for Ceftazidime-Avibactam in Adults with Complicated Intra-abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial Pneumonia

T. Riccobene, Jianguo Li, I. Critchley, 2019, Antimicrobial Agents and Chemotherapy.

Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimens.

D. Nicolau, T. Edeki, Shampa Das, 2015, The Journal of antimicrobial chemotherapy.

Ceftazidime-Avibactam Susceptibility Breakpoints against Enterobacteriaceae and Pseudomonas aeruginosa

T. Riccobene, I. Critchley, Shampa Das, 2018, Antimicrobial Agents and Chemotherapy.

Avibactam Pharmacokinetic/Pharmacodynamic Targets

T. Riccobene, I. Critchley, Shampa Das, 2018, Antimicrobial Agents and Chemotherapy.

Population PK Modeling and Target Attainment Simulations to Support Dosing of Ceftaroline Fosamil in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections and Community‐Acquired Bacterial Pneumonia

T. Riccobene, J. Bradley, W. Knebel, 2017, Journal of clinical pharmacology.

Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trials.

M. Wilcox, G. Corey, M. Dryden, 2019, International Journal of Antimicrobial Agents.

Determination of the safety and efficacy of therapeutic neutralization of tumor necrosis factor-α (TNF-α) using AZD9773, an anti-TNF-α immune Fab, in murine CLP sepsis

J. S. McKay, J. Yates, P. Newham, 2013, Inflammation Research.

Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria

F. Franceschi, M. Sharland, R. M. A. da Costa, 2021, Pediatric Drugs.

Binding characteristics, hormonal regulation and identity of the sperm membrane progestin receptor in Atlantic croaker

P. Thomas, C. Detweiler, Shampa Das, 2005, Steroids.

Pharmacodynamics of Meropenem and Tobramycin for Neonatal Meningoencephalitis: Novel Approaches to Facilitate the Development of New Agents to Address the Challenge of Antimicrobial Resistance

C. Hornik, J. Unsworth, W. Hope, 2022, Antimicrobial agents and chemotherapy.

Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance

R. Kolamunnage-Dona, F. Franceschi, M. Neely, 2022, The Journal of antimicrobial chemotherapy.

Intrapulmonary Pharmacokinetics of Cefepime and Enmetazobactam in Healthy Volunteers: Towards New Treatments for Nosocomial Pneumonia

P. Knechtle, A. Ullah, W. Hope, 2020, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of the Novel Metallo-β-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing Enterobacteriaceae

R. Kolamunnage-Dona, J. Unsworth, M. Everett, 2020, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing Klebsiella pneumoniae

R. Kolamunnage-Dona, G. Drusano, P. Knechtle, 2020, Antimicrobial Agents and Chemotherapy.

Population pharmacokinetic/pharmacodynamic modelling of the anti-TNF-α polyclonal fragment antibody AZD9773 in patients with severe sepsis

J. Yates, J. Kemp, Shampa Das, 2012, Journal of Pharmacokinetics and Pharmacodynamics.

Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients

Diansong Zhou, J. Romero, J. Bradley, 2016, Antimicrobial Agents and Chemotherapy.

Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients

Diansong Zhou, J. Romero, T. Edeki, 2016 .

Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression

S. Orkin, R. Bronson, C. Carman, 2003, Nature.

Upregulation of the Maturation-Inducing Steroid Membrane Receptor in Spotted Seatrout Ovaries by Gonadotropin During Oocyte Maturation and Its Physiological Significance1

P. Thomas, Shampa Das, J. Pinter, 2001, Biology of reproduction.

Steroid Membrane Receptor in Spotted Seatrout Ovaries

P. Thomas, Shampa Das, 2004 .

Population Pharmacokinetic Modeling and Probability of Target Attainment Analyses in Asian Patients With Community‐Acquired Pneumonia Treated With Ceftaroline Fosamil

Diansong Zhou, N. Al-Huniti, Jianguo Li, 2019, Clinical pharmacology in drug development.

Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections

Diansong Zhou, J. Yan, Jianguo Li, 2018, The Journal of antimicrobial chemotherapy.

Comparing probability of target attainment against Staphylococcus aureus for ceftaroline fosamil, vancomycin, daptomycin, linezolid, and ceftriaxone in complicated skin and soft tissue infection using pharmacokinetic/pharmacodynamic models.

James G. Wright, A. Cristinacce, Shampa Das, 2020, Diagnostic microbiology and infectious disease.

Proportion of low birth weight and related factors in a tertiary care institute of Tripura

Shampa Das, H. Bhattacharjya, D. Ghosh, 2015 .

Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance

R. Kolamunnage-Dona, F. Franceschi, M. Neely, 2021, Antimicrobial agents and chemotherapy.

Ceftazidime‐Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups

James G. Wright, Diansong Zhou, T. Riccobene, 2018, Clinical and translational science.

Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections

A. Dane, J. Unsworth, P. Ambrose, 2019, Antimicrobial Agents and Chemotherapy.

Determination of the safety and efficacy of therapeutic neutralization of tumor necrosis factor-α (TNF-α) using AZD9773, an anti-TNF-α immune Fab, in murine CLP sepsis

J. S. McKay, J. Yates, P. Newham, 2014, Inflammation Research.

Population pharmacokinetic/pharmacodynamic modelling of the anti-TNF-α polyclonal fragment antibody AZD9773 in patients with severe sepsis

J. Yates, J. Kemp, Shampa Das, 2012, Journal of Pharmacokinetics and Pharmacodynamics.

Re: In the name of common sense: EUCAST breakpoints and potential pitfalls. National dissemination of EUCAST guidelines is a shared responsibility

G. Lina, J. Turnidge, A. MacGowan, 2020, Clinical Microbiology and Infection.

Gender discrimination among professional college students in Agartala, India: a cross-sectional study

R. Das, Shampa Das, S. S. Debnath, 2016 .

A Study to Find Out the Full Immunization Coverage of 12 to 23-month old Children and Areas of Under-Performance using LQAS Technique in a Rural Area of Tripura.

Shampa Das, S. Baidya, A. Datta, 2017, Journal of clinical and diagnostic research : JCDR.

Phase I study assessing the safety, tolerability, and pharmacokinetics of avibactam and ceftazidime-avibactam in healthy Japanese volunteers.

T. Edeki, M. R. Bouw, Shampa Das, 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

A STUDY ON SATISFACTION OF PATIENTS ATTENDING OPD OF AGARTALA GOVERNMENT MEDICAL COLLEGE

Shampa Das, H. Bhattacharjya, 2014 .

A study of cardiovascular sympathetic function tests during different phases of menstrual cycle in young females

Shampa Das, S. Panja, Kaushik Samajdar, 2019, International Journal of Research in Medical Sciences.

Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings

R. Kolamunnage-Dona, M. Neely, M. Sharland, 2022, The Journal of antimicrobial chemotherapy.

Breast Feeding: Practices and Determinants in Rural Area of West Tripura District of India -

Shampa Das, H. Bhattacharjya, Chanda Mog, 2013 .

Antibody Responses of SARS-CoV-2 Vaccines amongst Health Care Workers in a Tertiary Care Hospital in Tripura, India: A Cross-Sectional Study

Shampa Das, S. Baidya, S. Bhattacharya, 2022, Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine.

Considerations in the Selection of Renal Dosage Adjustments for Patients with Serious Infections and Lessons Learned from the Development of Ceftazidime-Avibactam

T. Riccobene, Jianguo Li, Shampa Das, 2020, Antimicrobial Agents and Chemotherapy.

Population Pharmacokinetic Modelling of Ceftazidime and Avibactam in the Plasma and Epithelial Lining Fluid of Healthy Volunteers

James G. Wright, Shampa Das, P. Newell, 2018, Drugs in R&D.

Randomized pharmacokinetic and drug–drug interaction studies of ceftazidime, avibactam, and metronidazole in healthy subjects

T. Edeki, Jianguo Li, Shampa Das, 2015, Pharmacology research & perspectives.

A cross-sectional study to assess the immunization coverage and vaccine dropout rates among 12 to 23 months old children in a rural area of Tripura

Shampa Das, A. Datta, Chanda Mog, 2017 .

Phase I study of barasertib (AZD1152), a selective inhibitor of Aurora B kinase, in patients with advanced solid tumors

G. Shapiro, G. Schwartz, David M. Wilson, 2013, Investigational New Drugs.

Subject preference for future specialization among undergraduate medical students and their perception towards community medicine as a career option: a cross sectional study

R. Das, Shampa Das, Bitan Sengupta, 2019, International Journal of Community Medicine and Public Health.

Selecting the dosage of ceftazidime–avibactam in the perfect storm of nosocomial pneumonia

Diansong Zhou, Jianguo Li, Shampa Das, 2019, European Journal of Clinical Pharmacology.

Assessment of the Mass Balance Recovery and Metabolite Profile of Avibactam in Humans and In Vitro Drug-Drug Interaction Potential

Anshul Gupta, T. Edeki, K. Vishwanathan, 2014, Drug Metabolism and Disposition.

Clinical evaluation of AZD1152, an i.v. inhibitor of Aurora B kinase, in patients with solid malignant tumors.

J. Schellens, David M. Wilson, E. Voest, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Gender preference and factors affecting gender preference of mothers attending antenatal clinic of Agartala government medical college

Shampa Das, H. Bhattacharjya, Chanda Mog, 2014 .

A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock

G. Bernard, A. Bernard, P. Morris, 2012, Critical Care.

Phase 1 Study Assessing the Pharmacokinetic Profile and Safety of Avibactam in Patients With Renal Impairment

A. Tarral, Jianguo Li, H. Merdjan, 2017, Journal of clinical pharmacology.

Pharmacokinetics and tolerability of NXL 104 in normal subjects and in patients with varying degrees of renal insufficiency

A. Tarral, Jianguo Li, H. Merdjan, 2016 .

Randomized, placebo‐controlled study to assess the impact on QT/QTc interval of supratherapeutic doses of ceftazidime–avibactam or ceftaroline fosamil–avibactam

T. Edeki, Jianguo Li, Shampa Das, 2014, Journal of clinical pharmacology.

Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimens.

D. Nicolau, T. Edeki, Shampa Das, 2015, The Journal of antimicrobial chemotherapy.

Avibactam Pharmacokinetic/Pharmacodynamic Targets

T. Riccobene, I. Critchley, Shampa Das, 2018, Antimicrobial Agents and Chemotherapy.